Skip to content

The Impact of Sucrose Ingestion During Exercise on Liver and Muscle Glycogen Concentration.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02110836
Enrollment
14
Registered
2014-04-10
Start date
2014-04-30
Completion date
2015-04-30
Last updated
2015-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver and Muscle Glycogen Use During Exercise.

Brief summary

Carbohydrate is stored in the body as glycogen, which is mainly found in the liver and muscle. During endurance exercise, muscle glycogen is used as fuel for the working muscles and liver glycogen is broken down to provide glucose to maintain blood glucose (sugar) levels. Both liver and muscle glycogen are important for the ability to perform intense/prolonged endurance exercise. Therefore, nutritional strategies which can maximise the availability of glycogen in muscle and liver can benefit endurance exercise capacity. The carbohydrates typically found in sports drinks are glucose and sometimes fructose. If glucose only is ingested during exercise, then the maximum rate at which can be absorbed from the intestine into the blood stream is \ 1 g/min. However, if different sources of carbohydrate (fructose) are used, which are absorbed through a different pathway, absorption of carbohydrate can be up to \ 1.8 g/min. With more carbohydrate available as a fuel, this translates into an improvement in performance. Sucrose is a naturally occurring sugar that is made up of a single glucose and single fructose molecule. Therefore, theoretically, this can use the two different pathways of absorption and also maximise carbohydrate delivery. It is not yet known however, what impact this has on our liver and muscle glycogen stores during exercise. Therefore the aim of this study is to assess whether sucrose ingestion influences liver and muscle glycogen depletion during endurance exercise.

Interventions

DIETARY_SUPPLEMENTGlucose ingestion

Glucose ingestion during exercise at 1.8 g/min

DIETARY_SUPPLEMENTSucrose ingestion

Sucrose ingestion during exercise at 1.8 g/min

Sponsors

University of Newcastle Upon-Tyne
CollaboratorOTHER
Maastricht University
CollaboratorOTHER
Sugar Nutrition, UK
CollaboratorUNKNOWN
Javier Gonzalez, PhD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy * Male * 18 - 35 years of age * Endurance trained cyclist/triathlete * VO2 max ≥ 50 ml/kg/min

Exclusion criteria

* Use of medication * Smoking * Metabolic disorders

Design outcomes

Primary

MeasureTime frameDescription
Change in liver glycogen concentration3 hoursThe change in liver glycogen concentration will be determined pre-to-post 3 h of exercise using 13C magnetic resonance spectroscopy.

Secondary

MeasureTime frameDescription
Plasma lactate concentration3 hoursPlasma lactate concentrations will be determined every 30 min during 3 h of exercise.
Plasma non-esterified fatty acid concentration3 hoursPlasma non-esterified fatty acid concentrations will be determined every 30 min during 3 h of exercise.
Plasma glucose concentration.3 hoursPlasma glucose concentrations will be determined every 30 min during 3 h of exercise.
Muscle glycogen concentration3 hoursThe change in muscle glycogen concentration will be determined pre-to-post 3 h of exercise using 13C magnetic resonance spectroscopy.
Change in intramyocellular lipid concentration3 hoursThe change in intramyocellular lipid concentration will be determined pre-to-post 3 h of exercise using 1H magnetic resonance spectroscopy.
Indirect calorimetry3 hoursMeasurements of oxygen consumption, carbon dioxide production and respiratory exchange ratio through indirect calorimetry measured every 30 minutes during exercise.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026